ES356551A1 - A PROCEDURE FOR THE PREPARATION OF LONG-ACTING PHARMACEUTICAL COMPOSITIONS IN ADMINISTRABLE DOSES IN ORAL FORM. - Google Patents

A PROCEDURE FOR THE PREPARATION OF LONG-ACTING PHARMACEUTICAL COMPOSITIONS IN ADMINISTRABLE DOSES IN ORAL FORM.

Info

Publication number
ES356551A1
ES356551A1 ES356551A ES356551A ES356551A1 ES 356551 A1 ES356551 A1 ES 356551A1 ES 356551 A ES356551 A ES 356551A ES 356551 A ES356551 A ES 356551A ES 356551 A1 ES356551 A1 ES 356551A1
Authority
ES
Spain
Prior art keywords
drug
preparation
long
pharmaceutical compositions
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES356551A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COTTY
Original Assignee
COTTY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTTY filed Critical COTTY
Publication of ES356551A1 publication Critical patent/ES356551A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for the preparation of long-acting pharmaceutical compositions in orally administrable doses consisting of mixing a first drug (a) and a drug glucuronide (b), said drug glucuronide having been selected from the group consisting of a glucuronide of said first drug and drugs that exercise my analogous pharmacological action; the total amount of active drug contained in said composition being found at a therapeutically active level. (Machine-translation by Google Translate, not legally binding)
ES356551A 1967-08-01 1968-07-26 A PROCEDURE FOR THE PREPARATION OF LONG-ACTING PHARMACEUTICAL COMPOSITIONS IN ADMINISTRABLE DOSES IN ORAL FORM. Expired ES356551A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65749667A 1967-08-01 1967-08-01

Publications (1)

Publication Number Publication Date
ES356551A1 true ES356551A1 (en) 1970-02-01

Family

ID=24637422

Family Applications (1)

Application Number Title Priority Date Filing Date
ES356551A Expired ES356551A1 (en) 1967-08-01 1968-07-26 A PROCEDURE FOR THE PREPARATION OF LONG-ACTING PHARMACEUTICAL COMPOSITIONS IN ADMINISTRABLE DOSES IN ORAL FORM.

Country Status (4)

Country Link
BE (1) BE718710A (en)
ES (1) ES356551A1 (en)
FR (1) FR7749M (en)
NL (1) NL6810371A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832277A1 (en) * 1988-09-22 1990-03-29 Guenter Stephan effervescent tablet

Also Published As

Publication number Publication date
BE718710A (en) 1969-01-27
FR7749M (en) 1970-03-16
NL6810371A (en) 1969-02-04

Similar Documents

Publication Publication Date Title
ES488168A0 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL OR MEDICINAL TABLETS FOR ORAL ADMINISTRATION, WITH DELAYED DELIVERY OF ACTIVE ACTIVE, IN TABLETS IN WHICH THE QUANTITY OF RELEASE OF THE ACTIVE AGENT IS DEFAULT.
ZA711412B (en) Orally administrable drug dosage form having delayed action
DK112191B (en) Process for the preparation of pharmaceutical compositions for oral administration, such as granules, tablets, gelatin capsules or dragees.
ES403435A1 (en) Slow release pharmaceutical compositions
SE7416039L (en)
MY7400329A (en) Drug for use in pharmaceutical composition
PH13841A (en) Pharmaceutical preparation adapted for oral administration
BE811062A (en) FREE FLOWING PHARMACEUTICAL COMPOSITIONS THAT CAN BE TRANSFORMED DIRECTLY INTO TABLETS
JPS5241214A (en) Method of making preparations for oral administration
IL51096A0 (en) Novel pharmaceutical dosage form
IT1062053B (en) PHARMACEUTICALLY ACTIVE AMMINOGUANIDINE PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT COMMENGOMO
ES370058A1 (en) PROCEDURE FOR THE PREPARATION OF EFFERVESCENT PHARMACEUTICAL COMPOSITIONS.
DK123141B (en) Process for stabilizing a pharmaceutical composition suitable for oral administration, containing a basic dihydrodibenzazepine.
ES356551A1 (en) A PROCEDURE FOR THE PREPARATION OF LONG-ACTING PHARMACEUTICAL COMPOSITIONS IN ADMINISTRABLE DOSES IN ORAL FORM.
JPS52108028A (en) Remedies for dysacousis
DK120812B (en) Process for the preparation of a stable pharmaceutical composition based on estrone sulphate and estradiol-3-sulphate.
NL160722C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION BY CONTAINING A 6,6-DIFLUORSTEROID IN A FORM SUITABLE FOR THERAPEUTIC ADMINISTRATION, AND FORMED PREPARATION AND PROCEDURE FOR PREPARING THE ACTIVE COMPOUNDS.
ES449797A1 (en) 1,3,8-triazaspiro(4.5)decan-4-one derivatives
ES451880A1 (en) Toothpaste compostion
ES294897A1 (en) Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding)
ES362231A1 (en) Dimethylbiguanide Derivative
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
ES283585A1 (en) A procedure for the preparation of a therapeutic composition (Machine-translation by Google Translate, not legally binding)
ES375750A1 (en) A PROCEDURE FOR COMPOSING THERAPEUTIC COMPOSITIONS.
IL31294A0 (en) A new(hexafluoro-3,5-xylyl)-anthranilic acid and its salts,their preparation,and pharmaceutical compositions containing them